Irving E Salit
Affiliation: University of Toronto
- The role of cytology (Pap tests) and human papillomavirus testing in anal cancer screeningIrving E Salit
University Health Network, Toronto General Hospital, Ontario, Canada
AIDS 24:1307-13. 2010..To assess anal oncogenic human papillomavirus (HPV) and anal cytology as screening tests for detecting high-grade anal intraepithelial neoplasia (AIN 2+), as this is an immediate anal cancer precursor...
- Travel patterns and risk behaviour of HIV-positive people travelling internationallyIrving E Salit
Faculty of Medicine, University of Toronto, ON
CMAJ 172:884-8. 2005..These risks are even higher among immunocompromised people, such as those with HIV infection. We conducted a study to determine HIV-positive people's travel patterns and risk behaviours while abroad...
- A possible cluster of sexually transmitted Entamoeba histolytica: genetic analysis of a highly virulent strainIrving E Salit
Division of Infectious Diseases, Department of Medicine, University Health Network, Toronto General Hospital, Toronto, Ontario, Canada
Clin Infect Dis 49:346-53. 2009..Epidemiologically linked clusters of E. histolytica infection are rare in industrialized countries. We report such a sexually linked cluster in Canada...
- Screening for HIV-associated anal cancer: correlation of HPV genotypes, p16, and E6 transcripts with anal pathologyIrving E Salit
University Health Network, Toronto General Hospital, Toronto, Ontario, Canada
Cancer Epidemiol Biomarkers Prev 18:1986-92. 2009..HIV-positive men with a history of anal-receptive intercourse are at risk for anal cancer. We determined whether human papilloma virus (HPV) biomarkers were correlated with anal pathology in these men...
- Interobserver agreement in the interpretation of anal intraepithelial neoplasiaAlice Lytwyn
Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
Cancer 103:1447-56. 2005..76 to 0.94 for biopsy specimens. CONCLUSIONS: Agreement for cytologic and biopsy interpretations was generally at least moderate. Nevertheless, these results supported the need for disease indicators with greater reliability...
- Non-alcoholic fatty liver disease in HIV infection associated with altered hepatic fatty acid compositionBianca M Arendt
University Health Network, Dept of Medicine, Toronto, Ontario, Canada
Curr HIV Res 9:128-35. 2011..Changes may be due to impaired FA metabolism or suboptimal n-3 PUFA intake. The potential role of n-3 PUFA (e.g. fish oil) to treat or prevent HIV/NAFLD warrants further investigation...
- Cost-effectiveness of screening for anal precancers in HIV-positive menJonathan M C Lam
University of Toronto, Toronto General Hospital, Canada
AIDS 25:635-42. 2011..To assess the cost-effectiveness of high-resolution anoscopy (HRA), anal cytology, and anal human papillomavirus (HPV) detection in screening for histologic high-grade anal intraepithelial neoplasia (AIN 2/3) in HIV-positive MSM...
- In patients with HIV-infection, chromium supplementation improves insulin resistance and other metabolic abnormalities: a randomized, double-blind, placebo controlled trialElaheh Aghdassi
The University Health Network, The Toronto General Hospital, 200 Elizabeth St 9 N 973, Toronto, Ontario M5G2C4, Canada
Curr HIV Res 8:113-20. 2010..In summary, chromium improved insulin resistance, metabolic abnormalities, and body composition in HIV+ patients. This suggests that chromium supplements alleviate some of the antiretroviral-associated metabolic abnormalities...
- A survey on the usage of supplements in canadian patients living with HIVElaheh Aghdassi
The University Health Network, The Toronto Western Hospital, Toronto, Ontario, Canada
Curr HIV Res 7:555-61. 2009....
- Estimation of body fat mass using dual-energy x-ray absorptiometry, bioelectric impedance analysis, and anthropometry in HIV-positive male subjects receiving highly active antiretroviral therapyElaheh Aghdassi
University of Toronto, Toronto, Ontario, Canada
JPEN J Parenter Enteral Nutr 31:135-41. 2007..As different patterns of abdominal fat accumulation might affect the body FM estimation, correlation and agreement of these methods were also compared in patients with waist to hip ratio (WHR) < or =0.9 and >0.9...
- HIV-positive patients with nonalcoholic fatty liver disease have a lower body mass index and are more physically active than HIV-negative patientsSaira S Mohammed
Department of Medicine, University Health Network, University of Toronto, 200 Elizabeth Street, Toronto, Ontario, Canada
J Acquir Immune Defic Syndr 45:432-8. 2007..To determine whether the clinical and metabolic features associated with nonalcoholic fatty liver disease (NAFLD) are similar between HIV-positive and HIV-negative male subjects...
- Is chromium an important element in HIV-positive patients with metabolic abnormalities? An hypothesis generating pilot studyElaheh Aghdassi
Department of Medicine, The University Health Network, The Toronto General Hospital, 200 Elizabeth St, Eaton Wing, 9 Floor, Room 217a, Toronto, Ontario, M5G-2C4, Canada
J Am Coll Nutr 25:56-63. 2006..Low chromium levels may be due to increased chromium losses. These results support further studies on chromium in HIV patients...
- CD4+ cell count decline despite HIV suppression: a probable didanosine-valganciclovir interactionAlice L Tseng
Immunodeficiency Clinic, Toronto General Hospital, Toronto, Ontario, Canada
Ann Pharmacother 41:512-7. 2007..To describe a case of significant CD4+ cell decline despite complete viral suppression in an HIV-positive patient receiving didanosine and valganciclovir...
- Long-term quality-of-life outcomes among adults living with HIV in the HAART era: the interplay of changes in clinical factors and symptom profileRobert W Burgoyne
Immunodeficiency Clinic, Toronto General Hospital, Ontario, Canada
AIDS Behav 8:151-63. 2004..CD4 repletion offset negative effects of symptoms for some aspects of quality of life. The long-term course of quality of life was somewhat predicted by viral load suppression due to the conjoint influence of symptoms and CD4 count...